Duponte

What Duponte does

Duponte (legal entity DUPONTE INVESTIGACIÓN Y DESARROLLO, S.L.) is a Seville, Spain-based biotechnology company founded in 2019 that develops AI-enabled tools for clinical genomics. Its core product is Matchgénica, an AI-powered genetic analysis platform that organizes genomic variant data, associates patient genetic profiles with clinical guidelines, and supports therapeutic recommendation, early diagnosis, and collaborative interpretation for clinicians and biomedical researchers. The company is registered as a medical product developer compliant with EU Medical Device Regulation and GDPR, and operates from the CITIUS III University of Seville research complex with a 1–10 person team.

Duponte monetizes through a hybrid model spanning (i) Matchgénica platform licenses sold via direct demo and inquiry funnels to healthcare professionals and research institutions (predominantly in Spain), (ii) Duponte Academy, an educational division delivering courses and an own Master's degree in Personalized Medicine and Pharmacogenomics sold on a one-time/enrollment basis, (iii) fee-for-service custom gene panel and whole exome sequencing with data interpretation, (iv) personalized scientific and genetic consulting, and (v) 3R-compliant animal experimentation research services. Marketing is content-led, with an active bilingual blog on pharmacogenomics, genetics, and bioinformatics, supplemented by LinkedIn, Instagram, and Facebook channels and an investor-facing section on the corporate website.

The company is privately held with no disclosed funding rounds, no parent organization, no named enterprise customers, and a CEO (Yolima Puentes Osorio) at the helm. Strategic positioning combines a proprietary AI-driven interpretation platform with vertically integrated wet-lab services and a captive educational funnel, targeting healthcare professionals, researchers, recent health sciences graduates, and workforce re-entrants in the Spanish clinical genomics market.

Name

Duponte

Legal name

DUPONTE INVESTIGACIÓN Y DESARROLLO, S.L.

Website

https://duponteadn.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Duponte is a Seville-based biotechnology company that builds Matchgénica, an AI-powered genetic analysis platform for variant interpretation, complemented by genetic sequencing, scientific consulting, and Duponte Academy's pharmacogenomics training serving clinicians and biomedical researchers primarily in Spain.

Ownership category

akta.pro rank

Product category

Genomic Analysis Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology) (HLAMADAE)

Keywords

• Genomic analysis software
• Genetic sequencing services
• Pharmacogenomics education
• Biomedical research consulting
• Clinical genetics platform

Headquarters

HQ city

Sevilla

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Matchgénica Platform Licenses: AI-powered genetic analysis platform licensed to healthcare professionals, researchers, and institutions. Access is offered via license agreements, with a demo scheduling mechanism and FAQ page for prospective customers.
2. Duponte Academy Educational Programs: Scientific training programs including courses and a Master's degree (Own Master's in Personalized Medicine and Pharmacogenomics) sold to healthcare professionals, researchers, and recent graduates. Revenue generated through program matriculation fees.
3. Genetic Sequencing Service: Laboratory service offering genome exploration through customized gene panels, whole exome sequencing, and data interpretation, opening new pathways for biomedical research. Provided as a fee-for-service to researchers and healthcare institutions.
4. Scientific and Genetic Consulting: Personalized consulting services accompanying clients from project conception to final version, adapted to the particularities of each study.
5. Animal Experimentation Service: Biomedical research support service applying the 3R principles (Replacement, Reduction, Refinement) to design and develop protocols for biomedical innovation.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Duponte develops and sells Matchgénica, an AI-powered genetic analysis platform that performs variant interpretation and matches genetic profiles to clinical guidelines to support personalized therapeutic decisions. The company complements this software platform with fee-for-service genetic sequencing, animal experimentation research, scientific consulting, and educational programs (Duponte Academy) for healthcare professionals and researchers.

Product overview

Duponte is a biotechnology company offering a portfolio of genetic analysis products and services. The core offering is Matchgénica, an AI-powered genetic analysis platform that facilitates variant interpretation for clinical and research decision-making. Complementing the platform are genetic sequencing services, animal experimentation services (applied to biomedical research), genomic research connecting laboratory with clinical practice, and scientific consulting. The company also operates Duponte Academy, an educational division offering courses and the Master's Degree in Personalized Medicine and Pharmacogenomics, training healthcare professionals in genetic data interpretation.

Differentiator

Problem solved

Functional benefit

Brands

• Matchgénica: AI-powered genetic analysis platform designed to facilitate variant interpretation and support clinical and research work.
• Duponte Academy

Products and services

• Matchgénica Platform AI-powered genetic analysis platform with integrated variant interpretation for clinical and research use. Organizes genetic data clearly and matches genetic profiles to clinical guidelines to support personalized therapeutic recommendations, early diagnosis, and collaborative interpretation.
• Genetic Sequencing Service Laboratory sequencing service offering custom gene panels, whole exome sequencing, and data interpretation for biomedical research, available to researchers and healthcare institutions.
• Animal Experimentation Service Biomedical research support service designing and executing animal studies under the 3R principles (Replacement, Reduction, Refinement) to drive biomedical innovation for research clients.
• Genomic Research Applied genomic research service connecting laboratory analysis with clinical practice to improve diagnostics and treatments, leveraging Duponte's genetic expertise.
• Scientific and Personalized Genetic Consulting Personalized consulting engagement accompanying clients from project conception through final delivery, tailored to the specific requirements of each study in genetics and biomedical research.
• Duponte Academy Educational Programs Scientific training platform delivering courses that teach healthcare professionals, researchers, and students to interpret, analyze, and translate genetic data into clinical decisions.
• Master's Degree in Personalized Medicine and Pharmacogenomics (Máster Propio en Medicina Personalizada y Farmacogenómica) Own-titled Master's program providing advanced training in personalized medicine and pharmacogenomics, enabling professionals to incorporate genetics into clinical practice, with a 100% scholarship option for some beneficiaries.

Quantifiable outcome

• Reduces unnecessary tests and medication errors, lowering costs by up to 30%

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature1 record

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• SOPHiA Genetics: Swiss-based clinical genomics AI platform using next-generation sequencing data and proprietary algorithms to interpret variants for hospitals and research institutions — the most direct global competitor to Matchgénica.
• Congenica: UK-based clinical genomics interpretation platform focused on rare disease and oncology variant analysis; competes directly with Matchgénica for hospital and diagnostic-lab interpretation workflows.
• Fabric Genomics: AI-driven clinical genomic interpretation platform for hereditary disease and oncology; comparable AI-first interpretation architecture serving clinical labs and hospitals.
• DNAnexus: Cloud-based genomics data and analytics platform serving biomedical researchers and clinical users — overlapping in the genomic-data interpretation and collaboration use cases Duponte targets.
• Lifebit: Genomics and biomedical data platform combining federated analytics, interpretation, and AI tooling for research and clinical genomics — comparable technology and customer overlap.
• BC Platforms: Genomics data management and clinical interpretation platform serving hospitals and research biobanks across Europe; similar European footprint and clinical-genomics GTM.

Broad incumbents

• Tempus: Large U.S. precision-medicine platform combining genomic sequencing, AI interpretation, and clinical decision support; overlaps with Duponte's clinical-genomics mission at much broader scale.

Regional players

• Health in Code: Spanish clinical-genetics company offering genetic diagnostics, sequencing, and interpretation services to hospitals and clinicians in Spain and Portugal — the most direct regional competitor.
• Imegen: Spanish genetics laboratory providing sequencing, diagnostic, and clinical interpretation services to healthcare institutions — overlaps with Duponte's Spanish sequencing and clinical-genetics offering.
• Sistemas Genómicos: Spain-based clinical genetics and bioinformatics services provider with sequencing, interpretation, and bioinformatics offerings — comparable regional clinical-genomics stack.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/DuponteGroup
• LinkedInlinkedin.com/company/duponte-group
• Instagraminstagram.com/duponteacademy
• Xx.com/DuponteGroup

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Duponte